TreeWAS – Variant ID: rs4812973

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
C77.9 Lymph node, unspecified	0.007	0.993	0.000
D37-D48 Neoplasms of uncertain or unknown behaviour	0.006	0.994	0.000
D41.4 Bladder	0.006	0.994	0.000
H40.1 Primary open-angle glaucoma	0.000	0.994	0.006
D41 Neoplasm of uncertain or unknown behaviour of urinary organs	0.005	0.994	0.000
D47.1 Chronic myeloproliferative disease	0.005	0.995	0.000
D45 Polycythaemia vera	0.005	0.995	0.000
D47 Other neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.005	0.995	0.000
D46 Myelodysplastic syndromes	0.005	0.995	0.000
D46.9 Myelodysplastic syndrome, unspecified	0.005	0.995	0.000
D48 Neoplasm of uncertain or unknown behaviour of other and unspecified sites	0.005	0.995	0.000
D40 Neoplasm of uncertain or unknown behaviour of male genital organs	0.005	0.995	0.000
D37 Neoplasm of uncertain or unknown behaviour of oral cavity and digestive organs	0.005	0.995	0.000
D48.1 Connective and other soft tissue	0.005	0.995	0.000
D44 Neoplasm of uncertain or unknown behaviour of endocrine glands	0.004	0.996	0.000
D42 Neoplasm of uncertain or unknown behaviour of meninges	0.004	0.996	0.000
D48.0 Bone and articular cartilage	0.004	0.996	0.000
D39 Neoplasm of uncertain or unknown behaviour of female genital organs	0.004	0.996	0.000
D47.3 Essential (haemorrhagic) thrombocythaemia	0.004	0.996	0.000
D37.2 Small intestine	0.004	0.996	0.000
D41.9 Urinary organ, unspecified	0.004	0.996	0.000
D41.7 Other urinary organs	0.004	0.996	0.000
D41.3 Urethra	0.004	0.996	0.000
D41.2 Ureter	0.004	0.996	0.000
D41.1 Renal pelvis	0.004	0.996	0.000
D47.9 Neoplasm of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue, unspecified	0.004	0.996	0.000
D47.7 Other specified neoplasms of uncertain or unknown behaviour of lymphoid, haematopoietic and related tissue	0.004	0.996	0.000
D47.5 Chronic eosinophilic leukaemia [hypereosinophilic syndrome]	0.004	0.996	0.000
D47.4 Osteomyelofibrosis	0.004	0.996	0.000
D47.0 Histiocytic and mast cell tumours of uncertain and unknown behaviour	0.004	0.996	0.000
D46.7 Other myelodysplastic syndromes	0.004	0.996	0.000
D46.6 Myelodysplastic syndrome with isolated del(5q) chromosomal abnormality	0.004	0.996	0.000
D46.5 Refractory anaemia with multi-lineage dysplasia	0.004	0.996	0.000
D46.4 Refractory anaemia, unspecified	0.004	0.996	0.000
D46.3 Refractory anaemia with excess of blasts with transformation	0.004	0.996	0.000
D46.2 Refractory anaemia with excess of blasts	0.004	0.996	0.000
D46.1 Refractory anaemia with sideroblasts	0.004	0.996	0.000
D46.0 Refractory anaemia without sideroblasts, so stated	0.004	0.996	0.000
D38 Neoplasm of uncertain or unknown behaviour of middle ear and respiratory and intrathoracic organs	0.004	0.996	0.000
D43 Neoplasm of uncertain or unknown behaviour of brain and central nervous system	0.004	0.996	0.000
M47.96 Spondylosis, unspecified (Lumbar region)	0.004	0.996	0.000
D40.1 Testis	0.004	0.996	0.000
D40.0 Prostate	0.004	0.996	0.000
D37.6 Liver, gallbladder and bile ducts	0.004	0.996	0.000
D37.0 Lip, oral cavity and pharynx	0.004	0.996	0.000
D48.9 Neoplasms of uncertain or unknown behaviour, unspecified	0.004	0.996	0.000
D48.7 Other specified sites	0.004	0.996	0.000
D48.4 Peritoneum	0.004	0.996	0.000
D48.3 Retroperitoneum	0.004	0.996	0.000
D48.2 Peripheral nerves and autonomic nervous system	0.004	0.996	0.000
R50.9 Fever, unspecified	0.004	0.996	0.000
H40 Glaucoma	0.000	0.996	0.004
O70.2 Third degree perineal laceration during delivery	0.004	0.996	0.000
D41.0 Kidney	0.004	0.996	0.000
D40.9 Male genital organ, unspecified	0.004	0.996	0.000
D40.7 Other male genital organs	0.004	0.996	0.000
D37.1 Stomach	0.004	0.996	0.000
D37.9 Digestive organ, unspecified	0.003	0.996	0.000
D37.3 Appendix	0.003	0.996	0.000
D48.6 Breast	0.003	0.996	0.000
D39.9 Female genital organ, unspecified	0.003	0.997	0.000
D39.7 Other female genital organs	0.003	0.997	0.000
D39.2 Placenta	0.003	0.997	0.000
D39.0 Uterus	0.003	0.997	0.000
D42.9 Meninges, unspecified	0.003	0.997	0.000
D42.1 Spinal meninges	0.003	0.997	0.000
D42.0 Cerebral meninges	0.003	0.997	0.000
D44.9 Endocrine gland, unspecified	0.003	0.997	0.000
D44.8 Pluriglandular involvement	0.003	0.997	0.000
D44.7 Aortic body and other paraganglia	0.003	0.997	0.000
D44.6 Carotid body	0.003	0.997	0.000
D44.5 Pineal gland	0.003	0.997	0.000
D44.4 Craniopharyngeal duct	0.003	0.997	0.000
D44.3 Pituitary gland	0.003	0.997	0.000
D44.2 Parathyroid gland	0.003	0.997	0.000
D44.1 Adrenal gland	0.003	0.997	0.000
D44.0 Thyroid gland	0.003	0.997	0.000
H40.2 Primary angle-closure glaucoma	0.000	0.997	0.003
D39.1 Ovary	0.003	0.997	0.000
K29.7 Gastritis, unspecified	0.000	0.997	0.003
O70.0 First degree perineal laceration during delivery	0.003	0.997	0.000
D47.2 Monoclonal gammopathy	0.003	0.997	0.000
D48.5 Skin	0.003	0.997	0.000
E14.9 Without complications	0.003	0.997	0.000
O70 Perineal laceration during delivery	0.003	0.997	0.000
D38.6 Respiratory organ, unspecified	0.003	0.997	0.000
D38.5 Other respiratory organs	0.003	0.997	0.000
D38.4 Thymus	0.003	0.997	0.000
D38.3 Mediastinum	0.003	0.997	0.000
D38.2 Pleura	0.003	0.997	0.000
D38.0 Larynx	0.003	0.997	0.000
D43.9 Central nervous system, unspecified	0.003	0.997	0.000
D43.7 Other parts of central nervous system	0.003	0.997	0.000
D43.4 Spinal cord	0.003	0.997	0.000
D43.3 Cranial nerves	0.003	0.997	0.000
D43.1 Brain, infratentorial	0.003	0.997	0.000
D43.0 Brain, supratentorial	0.003	0.997	0.000
H40.9 Glaucoma, unspecified	0.000	0.997	0.003
K29.8 Duodenitis	0.000	0.997	0.003
D37.5 Rectum	0.003	0.997	0.000
D37.7 Other digestive organs	0.003	0.997	0.000
H40.6 Glaucoma secondary to drugs	0.000	0.997	0.003
H40.4 Glaucoma secondary to eye inflammation	0.000	0.997	0.003
H40.3 Glaucoma secondary to eye trauma	0.000	0.997	0.003
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.003	0.997	0.000
D38.1 Trachea, bronchus and lung	0.003	0.997	0.000
Z35.5 Supervision of elderly primigravida	0.003	0.997	0.000
H40.5 Glaucoma secondary to other eye disorders	0.000	0.997	0.003
D43.2 Brain, unspecified	0.003	0.997	0.000
D37.4 Colon	0.003	0.997	0.000
O70.9 Perineal laceration during delivery, unspecified	0.003	0.997	0.000
H40.8 Other glaucoma	0.000	0.997	0.003
Z92.3 Personal history of irradiation	0.003	0.997	0.000
H40.0 Glaucoma suspect	0.000	0.997	0.003
Z35.0 Supervision of pregnancy with history of infertility	0.003	0.997	0.000
O70.3 Fourth degree perineal laceration during delivery	0.002	0.997	0.000
O68.1 Labour and delivery complicated by meconium in amniotic fluid	0.003	0.997	0.000
O60-O75 Complications of labour and delivery	0.003	0.997	0.000
K29.1 Other acute gastritis	0.000	0.997	0.003
K91.4 Colostomy and enterostomy malfunction	0.003	0.997	0.000
O68 Labour and delivery complicated by foetal stress [distress]	0.003	0.997	0.000
D23.1 Skin of eyelid, including canthus	0.002	0.998	0.000
C77.4 Inguinal and lower limb lymph nodes	0.002	0.998	0.000
Z85.3 Personal history of malignant neoplasm of breast	0.002	0.998	0.000
O62 Abnormalities of forces of labour	0.002	0.998	0.000
O68.3 Labour and delivery complicated by biochemical evidence of foetal stress	0.002	0.998	0.000
O73 Retained placenta and membranes, without haemorrhage	0.002	0.998	0.000
Z35 Supervision of high-risk pregnancy	0.002	0.998	0.000
O71 Other obstetric trauma	0.002	0.998	0.000
O62.3 Precipitate labour	0.002	0.998	0.000
O68.8 Labour and delivery complicated by other evidence of foetal stress	0.002	0.998	0.000
O66 Other obstructed labour	0.002	0.998	0.000
C77 Secondary and unspecified malignant neoplasm of lymph nodes	0.002	0.998	0.000
O61 Failed induction of labour	0.002	0.998	0.000
O74 Complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O65 Obstructed labour due to maternal pelvic abnormality	0.002	0.998	0.000
O60 Preterm delivery	0.002	0.998	0.000
O66.0 Obstructed labour due to shoulder dystocia	0.002	0.998	0.000
O73.0 Retained placenta, without haemorrhage	0.002	0.998	0.000
Z35.4 Supervision of pregnancy with grand multiparity	0.002	0.998	0.000
O69 Labour and delivery complicated by umbilical cord complications	0.002	0.998	0.000
R33 Retention of urine	0.002	0.998	0.000
O63.0 Prolonged first stage (of labour)	0.002	0.998	0.000
I35.0 Aortic (valve) stenosis	0.002	0.998	0.000
C73 Malignant neoplasm of thyroid gland	0.002	0.998	0.000
O71.4 Obstetric high vaginal laceration alone	0.002	0.998	0.000
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
O63 Long labour	0.002	0.998	0.000
C77.8 Lymph nodes of multiple regions	0.002	0.998	0.000
N50.8 Other specified disorders of male genital organs	0.000	0.998	0.002
O67 Labour and delivery complicated by intrapartum haemorrhage, not elsewhere classified	0.002	0.998	0.000
O64 Obstructed labour due to malposition and malpresentation of foetus	0.002	0.998	0.000
R04.0 Epistaxis	0.002	0.998	0.000
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
C77.0 Lymph nodes of head, face and neck	0.002	0.998	0.000
O62.0 Primary inadequate contractions	0.002	0.998	0.000
O68.2 Labour and delivery complicated by foetal heart rate anomaly with meconium in amniotic fluid	0.002	0.998	0.000
O72.0 Third-stage haemorrhage	0.002	0.998	0.000
C83 Diffuse non-Hodgkin's lymphoma	0.002	0.998	0.000
O62.9 Abnormality of forces of labour, unspecified	0.002	0.998	0.000
O62.8 Other abnormalities of forces of labour	0.002	0.998	0.000
O62.4 Hypertonic, incoordinate and prolonged uterine contractions	0.002	0.998	0.000
O62.1 Secondary uterine inertia	0.002	0.998	0.000
O61.0 Failed medical induction of labour	0.002	0.998	0.000
O73.1 Retained portions of placenta and membranes, without haemorrhage	0.002	0.998	0.000
Z35.9 Supervision of high-risk pregnancy, unspecified	0.002	0.998	0.000
Z35.8 Supervision of other high-risk pregnancies	0.002	0.998	0.000
Z35.7 Supervision of high-risk pregnancy due to social problems	0.002	0.998	0.000
Z35.6 Supervision of very young primigravida	0.002	0.998	0.000
Z35.3 Supervision of pregnancy with history of insufficient antenatal care	0.002	0.998	0.000
O71.9 Obstetric trauma, unspecified	0.002	0.998	0.000
O71.8 Other specified obstetric trauma	0.002	0.998	0.000
O71.7 Obstetric haematoma of pelvis	0.002	0.998	0.000
O71.6 Obstetric damage to pelvic joints and ligaments	0.002	0.998	0.000
O71.5 Other obstetric injury to pelvic organs	0.002	0.998	0.000
O71.3 Obstetric laceration of cervix	0.002	0.998	0.000
O71.2 Postpartum inversion of uterus	0.002	0.998	0.000
O71.1 Rupture of uterus during labour	0.002	0.998	0.000
O71.0 Rupture of uterus before onset of labour	0.002	0.998	0.000
O72 Postpartum haemorrhage	0.002	0.998	0.000
I80.1 Phlebitis and thrombophlebitis of femoral vein	0.002	0.998	0.000
O66.9 Obstructed labour, unspecified	0.002	0.998	0.000
O66.8 Other specified obstructed labour	0.002	0.998	0.000
O66.4 Failed trial of labour, unspecified	0.002	0.998	0.000
O66.3 Obstructed labour due to other abnormalities of foetus	0.002	0.998	0.000
O66.2 Obstructed labour due to unusually large foetus	0.002	0.998	0.000
O66.1 Obstructed labour due to locked twins	0.002	0.998	0.000
O68.9 Labour and delivery complicated by foetal stress, unspecified	0.002	0.998	0.000
O69.8 Labour and delivery complicated by other cord complications	0.002	0.998	0.000
O69.1 Labour and delivery complicated by cord around neck, with compression	0.002	0.998	0.000
Z35.1 Supervision of pregnancy with history of abortive outcome	0.002	0.998	0.000
C73-C75 Malignant neoplasms of thyroid and other endocrine glands	0.002	0.998	0.000
C74.9 Adrenal gland, unspecified	0.002	0.998	0.000
D23.9 Skin, unspecified	0.002	0.998	0.000
O61.9 Failed induction of labour, unspecified	0.002	0.998	0.000
O61.8 Other failed induction of labour	0.002	0.998	0.000
O61.1 Failed instrumental induction of labour	0.002	0.998	0.000
C83.1 Small cleaved cell (diffuse)	0.002	0.998	0.000
C74 Malignant neoplasm of adrenal gland	0.002	0.998	0.000
O62.2 Other uterine inertia	0.002	0.998	0.000
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
D35.2 Pituitary gland	0.002	0.998	0.000
M47.9 Spondylosis, unspecified	0.002	0.998	0.000
O60.3 Preterm delivery without spontaneous labour	0.002	0.998	0.000
O60.2 Preterm spontaneous labour with term delivery	0.002	0.998	0.000
O60.1 Preterm spontaneous labour with preterm delivery	0.002	0.998	0.000
O60.0 Preterm labour without delivery	0.002	0.998	0.000
O65.9 Obstructed labour due to maternal pelvic abnormality, unspecified	0.002	0.998	0.000
O65.8 Obstructed labour due to other maternal pelvic abnormalities	0.002	0.998	0.000
O65.5 Obstructed labour due to abnormality of maternal pelvic organs	0.002	0.998	0.000
O65.4 Obstructed labour due to foetopelvic disproportion, unspecified	0.002	0.998	0.000
O65.3 Obstructed labour due to pelvic outlet and midcavity contraction	0.002	0.998	0.000
O65.2 Obstructed labour due to pelvic inlet contraction	0.002	0.998	0.000
O65.1 Obstructed labour due to generally contracted pelvis	0.002	0.998	0.000
O65.0 Obstructed labour due to deformed pelvis	0.002	0.998	0.000
O74.9 Complication of anaesthesia during labour and delivery, unspecified	0.002	0.998	0.000
O74.8 Other complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.7 Failed or difficult intubation during labour and delivery	0.002	0.998	0.000
O74.6 Other complications of spinal and epidural anaesthesia during labour and delivery	0.002	0.998	0.000
O74.5 Spinal and epidural anaesthesia-induced headache during labour and delivery	0.002	0.998	0.000
O74.4 Toxic reaction to local anaesthesia during labour and delivery	0.002	0.998	0.000
O74.3 Central nervous system complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.2 Cardiac complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.1 Other pulmonary complications of anaesthesia during labour and delivery	0.002	0.998	0.000
O74.0 Aspiration pneumonitis due to anaesthesia during labour and delivery	0.002	0.998	0.000
O69.9 Labour and delivery complicated by cord complication, unspecified	0.002	0.998	0.000
O69.5 Labour and delivery complicated by vascular lesion of cord	0.002	0.998	0.000
O69.4 Labour and delivery complicated by vasa praevia	0.002	0.998	0.000
O69.3 Labour and delivery complicated by short cord	0.002	0.998	0.000
O69.0 Labour and delivery complicated by prolapse of cord	0.002	0.998	0.000
M47.99 Spondylosis, unspecified (Site unspecified)	0.002	0.998	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.002	0.998	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.002	0.998	0.000
C85.0 Lymphosarcoma	0.002	0.998	0.000
Y51.7 Beta-Adrenoreceptor antagonists, not elsewhere classified	0.002	0.998	0.000
D23 Other benign neoplasms of skin	0.002	0.998	0.000
O75 Other complications of labour and delivery, not elsewhere classified	0.002	0.998	0.000
O63.2 Delayed delivery of second twin, triplet, etc.	0.002	0.998	0.000
O68.0 Labour and delivery complicated by foetal heart rate anomaly	0.002	0.998	0.000
D51.0 Vitamin B12 deficiency anaemia due to intrinsic factor deficiency	0.002	0.998	0.000
O64.9 Obstructed labour due to malposition and malpresentation, unspecified	0.002	0.998	0.000
O64.8 Obstructed labour due to other malposition and malpresentation	0.002	0.998	0.000
O64.5 Obstructed labour due to compound presentation	0.002	0.998	0.000
O64.4 Obstructed labour due to shoulder presentation	0.002	0.998	0.000
O64.3 Obstructed labour due to brow presentation	0.002	0.998	0.000
O64.2 Obstructed labour due to face presentation	0.002	0.998	0.000
O64.1 Obstructed labour due to breech presentation	0.002	0.998	0.000
O67.8 Other intrapartum haemorrhage	0.001	0.998	0.000
O67.0 Intrapartum haemorrhage with coagulation defect	0.001	0.998	0.000
D23.2 Skin of ear and external auricular canal	0.002	0.998	0.000
H53.1 Subjective visual disturbances	0.002	0.998	0.000
Y52.3 Coronary vasodilators, not elsewhere classified	0.002	0.998	0.000
K29 Gastritis and duodenitis	0.000	0.998	0.002
D23.4 Skin of scalp and neck	0.002	0.998	0.000
K76.6 Portal hypertension	0.000	0.998	0.002
N02.9 Unspecified	0.002	0.998	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.002	0.998	0.000
H40-H42 Glaucoma	0.000	0.998	0.002
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.002	0.998	0.000
C83.7 Burkitt's tumour	0.002	0.998	0.000
C83.6 Undifferentiated (diffuse)	0.002	0.998	0.000
C83.5 Lymphoblastic (diffuse)	0.002	0.998	0.000
C83.4 Immunoblastic (diffuse)	0.002	0.998	0.000
C83.2 Mixed small and large cell (diffuse)	0.002	0.998	0.000
Z35.2 Supervision of pregnancy with other poor reproductive or obstetric history	0.002	0.998	0.000
C91 Lymphoid leukaemia	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.002	0.998	0.000
C91.4 Hairy-cell leukaemia	0.002	0.998	0.000
O66.5 Failed application of vacuum extractor and forceps, unspecified	0.001	0.998	0.000
Y51 Drugs primarily affecting the autonomic nervous system	0.002	0.998	0.000
O67.9 Intrapartum haemorrhage, unspecified	0.001	0.998	0.000
O72.3 Postpartum coagulation defects	0.001	0.998	0.000
C88 Malignant immunoproliferative diseases	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
S82.30 Fracture of lower end of tibia (closed)	0.002	0.998	0.000
C83.3 Large cell (diffuse)	0.002	0.998	0.000
D06.9 Cervix, unspecified	0.002	0.998	0.000
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
Y52 Agents primarily affecting the cardiovascular system	0.002	0.998	0.000
O64.0 Obstructed labour due to incomplete rotation of foetal head	0.001	0.998	0.000
Z09.0 Follow-up examination after surgery for other conditions	0.000	0.998	0.002
C75 Malignant neoplasm of other endocrine glands and related structures	0.001	0.998	0.000
C74.1 Medulla of adrenal gland	0.001	0.998	0.000
C74.0 Cortex of adrenal gland	0.001	0.998	0.000
H00.1 Chalazion	0.000	0.998	0.002
O75.8 Other specified complications of labour and delivery	0.001	0.998	0.000
Y48.3 Local anaesthetics	0.001	0.998	0.000
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.001	0.998	0.000
F22.0 Delusional disorder	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.998	0.000
C95 Leukaemia of unspecified cell type	0.001	0.998	0.000
C94 Other leukaemias of specified cell type	0.001	0.998	0.000
C93 Monocytic leukaemia	0.001	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.001	0.998	0.000
C84 Peripheral and cutaneous T-cell lymphomas	0.001	0.998	0.000
M47.98 Spondylosis, unspecified (Sacral and sacrococcygeal region)	0.001	0.998	0.000
M47.95 Spondylosis, unspecified (Thoracolumbar region)	0.001	0.998	0.000
M47.94 Spondylosis, unspecified (Thoracic region)	0.001	0.998	0.000
M47.93 Spondylosis, unspecified (Cervicothoracic region)	0.001	0.998	0.000
M47.91 Spondylosis, unspecified (Occipito-atlanto-axial region)	0.001	0.998	0.000
M48.09 Spinal stenosis (Site unspecified)	0.002	0.998	0.000
D35.1 Parathyroid gland	0.002	0.998	0.000
O69.2 Labour and delivery complicated by other cord entanglement	0.001	0.998	0.000
Y43.3 Other antineoplastic drugs	0.002	0.998	0.000
G20 Parkinson's disease	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.001	0.998	0.000
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M48.06 Spinal stenosis (Lumbar region)	0.002	0.998	0.000
O75.9 Complication of labour and delivery, unspecified	0.001	0.998	0.000
O75.5 Delayed delivery after artificial rupture of membranes	0.001	0.998	0.000
O75.4 Other complications of obstetric surgery and procedures	0.001	0.998	0.000
O75.3 Other infection during labour	0.001	0.998	0.000
O75.1 Shock during or following labour and delivery	0.001	0.998	0.000
O75.0 Maternal distress during labour and delivery	0.001	0.998	0.000
D06 Carcinoma in situ of cervix uteri	0.001	0.998	0.000
C88.0 Waldenstrom's macroglobulinaemia	0.001	0.998	0.000
D07.1 Vulva	0.001	0.998	0.000
D23.6 Skin of upper limb, including shoulder	0.001	0.998	0.000
I31.9 Disease of pericardium, unspecified	0.000	0.998	0.001
D35 Benign neoplasm of other and unspecified endocrine glands	0.001	0.998	0.000
K91 Postprocedural disorders of digestive system, not elsewhere classified	0.002	0.998	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.001	0.998	0.000
K29.9 Gastroduodenitis, unspecified	0.000	0.998	0.001
O72.2 Delayed and secondary postpartum haemorrhage	0.001	0.998	0.000
Y52.2 Other antidysrhythmic drugs, not elsewhere classified	0.001	0.998	0.000
S02.10 Fracture of base of skull (closed)	0.000	0.999	0.001
C82.6 Cutaneous follicle centre lymphoma	0.001	0.999	0.000
C82.5 Diffuse follicle centre lymphoma	0.001	0.999	0.000
C82.4 Follicular lymphoma grade IIIb	0.001	0.999	0.000
C82.3 Follicular lymphoma grade IIIa	0.001	0.999	0.000
C82.2 Large cell, follicular	0.001	0.999	0.000
C82.1 Mixed small cleaved and large cell, follicular	0.001	0.999	0.000
C82.0 Small cleaved cell, follicular	0.001	0.999	0.000
C91.0 Acute lymphoblastic leukaemia	0.001	0.999	0.000
D23.0 Skin of lip	0.001	0.999	0.000
E83.4 Disorders of magnesium metabolism	0.001	0.999	0.000
X60.8 Other specified place	0.001	0.999	0.000
Y43.0 Antiallergic and antiemetic drugs	0.001	0.999	0.000
H42 Glaucoma in diseases classified elsewhere	0.000	0.999	0.001
Y54 Agents primarily affecting water-balance and mineral and uric acid metabolism	0.001	0.999	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.001	0.999	0.000
C91.9 Lymphoid leukaemia, unspecified	0.001	0.999	0.000
C91.8 Mature B-cell leukaemia Burkitt-type	0.001	0.999	0.000
C91.7 Other lymphoid leukaemia	0.001	0.999	0.000
C91.6 Prolymphocytic leukaemia of T-cell type	0.001	0.999	0.000
C91.5 Adult T-cell leukaemia	0.001	0.999	0.000
C91.3 Prolymphocytic leukaemia	0.001	0.999	0.000
C91.2 Subacute lymphocytic leukaemia	0.001	0.999	0.000
K29.3 Chronic superficial gastritis	0.000	0.999	0.001
O63.9 Long labour, unspecified	0.001	0.999	0.000
O63.1 Prolonged second stage (of labour)	0.001	0.999	0.000
Y51.9 Other and unspecified drugs primarily affecting the autonomic nervous system	0.001	0.999	0.000
Y51.8 Centrally acting and adrenergic-neuron-blocking agents, not elsewhere classified	0.001	0.999	0.000
Y51.6 @-Adrenoreceptor antagonists, not elsewhere classified	0.001	0.999	0.000
Y51.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.001	0.999	0.000
Y51.3 Other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, not elsewhere classified	0.001	0.999	0.000
Y51.2 Ganglionic blocking drugs, not elsewhere classified	0.001	0.999	0.000
Y51.1 Other parasympathomimetics [cholinergics]	0.001	0.999	0.000
Y51.0 Anticholinesterase agents	0.001	0.999	0.000
C88.9 Malignant immunoproliferative disease, unspecified	0.001	0.999	0.000
C88.7 Other malignant immunoproliferative diseases	0.001	0.999	0.000
C88.4 Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue [MALT-lymphoma]	0.001	0.999	0.000
C88.3 Immunoproliferative small intestinal disease	0.001	0.999	0.000
C88.2 Gamma heavy chain disease	0.001	0.999	0.000
C88.1 Alpha heavy chain disease	0.001	0.999	0.000
O90.8 Other complications of the puerperium, not elsewhere classified	0.001	0.999	0.000
Y43.9 Primarily systemic agent, unspecified	0.001	0.999	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.001	0.999	0.000
Y43.6 Enzymes, not elsewhere classified	0.001	0.999	0.000
Y43.5 Acidifying and alkalising agents	0.001	0.999	0.000
Y43.2 Antineoplastic natural products	0.001	0.999	0.000
D00-D09 In situ neoplasms	0.001	0.999	0.000
M47.90 Spondylosis, unspecified (Multiple sites in spine)	0.001	0.999	0.000
C75.9 Endocrine gland, unspecified	0.001	0.999	0.000
C75.8 Pluriglandular involvement, unspecified	0.001	0.999	0.000
C75.5 Aortic body and other paraganglia	0.001	0.999	0.000
C75.4 Carotid body	0.001	0.999	0.000
C75.3 Pineal gland	0.001	0.999	0.000
C75.2 Craniopharyngeal duct	0.001	0.999	0.000
C75.1 Pituitary gland	0.001	0.999	0.000
C75.0 Parathyroid gland	0.001	0.999	0.000
Y49.2 Other and unspecified antidepressants	0.001	0.999	0.000
Y52.9 Other and unspecified agents primarily affecting the cardiovascular system	0.001	0.999	0.000
Y52.8 Antivaricose drugs, including sclerosing agents	0.001	0.999	0.000
Y52.7 Peripheral vasodilators	0.001	0.999	0.000
Y52.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.001	0.999	0.000
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.001	0.999	0.000
Y52.1 Calcium-channel blockers	0.001	0.999	0.000
Y52.0 Cardiac-stimulant glycosides and drugs of similar action	0.001	0.999	0.000
Y44 Agents primarily affecting blood constituents	0.001	0.999	0.000
Chapter II Neoplasms	0.001	0.999	0.000
H93.1 Tinnitus	0.001	0.999	0.000
D07 Carcinoma in situ of other and unspecified genital organs	0.001	0.999	0.000
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.001	0.999	0.000
M79.86 Other specified soft tissue disorders (Lower leg)	0.000	0.999	0.001
S82.80 Fractures of other parts of lower leg (closed)	0.001	0.999	0.000
C84.9 Mature T/NK-cell lymphoma, unspecified	0.001	0.999	0.000
C84.8 Cutaneous T-cell lymphoma, unspecified	0.001	0.999	0.000
C84.7 Anaplastic large cell lymphoma, ALK-negative	0.001	0.999	0.000
C84.6 Anaplastic large cell lymphoma, ALK-positive	0.001	0.999	0.000
C84.5 Other and unspecified T-cell lymphomas	0.001	0.999	0.000
C84.4 Peripheral T-cell lymphoma	0.001	0.999	0.000
C84.3 Lymphoepithelioid lymphoma	0.001	0.999	0.000
C84.2 T-zone lymphoma	0.001	0.999	0.000
C84.1 Sezary's diease	0.001	0.999	0.000
C84.0 Mycosis fungoides	0.001	0.999	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.999	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.999	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.999	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.999	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.999	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.999	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.999	0.000
C93.9 Monocytic leukaemia, unspecified	0.001	0.999	0.000
C93.7 Other monocytic leukaemia	0.001	0.999	0.000
C93.3 Juvenile myelomonocytic leukaemia	0.001	0.999	0.000
C93.2 Subacute monocytic leukaemia	0.001	0.999	0.000
C93.1 Chronic monocytic leukaemia	0.001	0.999	0.000
C93.0 Acute monocytic leukaemia	0.001	0.999	0.000
C94.7 Other specified leukaemias	0.001	0.999	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.999	0.000
C94.5 Acute myelofibrosis	0.001	0.999	0.000
C94.4 Acute panmyelosis	0.001	0.999	0.000
C94.3 Mast cell leukaemia	0.001	0.999	0.000
C94.2 Acute megakaryoblastic leukaemia	0.001	0.999	0.000
C94.1 Chronic erythraemia	0.001	0.999	0.000
C94.0 Acute erythraemia and erythroleukaemia	0.001	0.999	0.000
C95.9 Leukaemia, unspecified	0.001	0.999	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.999	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.999	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.999	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.999	0.000
C96.9 Malignant neoplasms of lymphoid, haematopoietic and related tissue, unspecified	0.001	0.999	0.000
C96.8 Histiocytic sarcoma	0.001	0.999	0.000
C96.7 Other specified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.001	0.999	0.000
C96.6 Unifocal Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.5 Multifocal and unisystemic Langerhans-cell histiocytosis	0.001	0.999	0.000
C96.4 Sarcoma of dendritic cells (accessory cells)	0.001	0.999	0.000
C96.3 True histiocytic lymphoma	0.001	0.999	0.000
C96.2 Malignant mast cell tumour	0.001	0.999	0.000
C96.1 Malignant histiocytosis	0.001	0.999	0.000
C96.0 Letterer-Siwe disease	0.001	0.999	0.000
K91.0 Vomiting following gastro-intestinal surgery	0.001	0.999	0.000
O75.7 Vaginal delivery following previous Caesarean section	0.001	0.999	0.000
O75.2 Pyrexia during labour, not elsewhere classified	0.001	0.999	0.000
Y48.5 Therapeutic gases	0.001	0.999	0.000
Y48.4 Anaesthetic, unspecified	0.001	0.999	0.000
Y48.2 Other and unspecified general anaesthetics	0.001	0.999	0.000
Y48.1 Parenteral anaesthetics	0.001	0.999	0.000
Y48.0 Inhaled anaesthetics	0.001	0.999	0.000
Y54.3 Benzothiadiazine derivatives	0.001	0.999	0.000
Y59 Other and unspecified vaccines and biological substances	0.001	0.999	0.000
Y58 Bacterial vaccines	0.001	0.999	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.001	0.999	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.001	0.999	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.001	0.999	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.001	0.999	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.001	0.999	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.999	0.000
K74.6 Other and unspecified cirrhosis of liver	0.000	0.999	0.001
C90 Multiple myeloma and malignant plasma cell neoplasms	0.001	0.999	0.000
C81 Hodgkin's disease	0.001	0.999	0.000
Y57 Other and unspecified drugs and medicaments	0.001	0.999	0.000
C97-C97 Malignant neoplasms of independent (primary) multiple sites	0.001	0.999	0.000
D06.7 Other parts of cervix	0.001	0.999	0.000
D06.1 Exocervix	0.001	0.999	0.000
D06.0 Endocervix	0.001	0.999	0.000
D23.5 Skin of trunk	0.001	0.999	0.000
K91.3 Postoperative intestinal obstruction	0.001	0.999	0.000
Z03.8 Observation for other suspected diseases and conditions	0.000	0.999	0.001
C49 Malignant neoplasm of other connective and soft tissue	0.001	0.999	0.000
E14 Unspecified diabetes mellitus	0.001	0.999	0.000
D35.9 Endocrine gland, unspecified	0.001	0.999	0.000
D35.8 Pluriglandular involvement	0.001	0.999	0.000
D35.7 Other specified endocrine glands	0.001	0.999	0.000
D35.6 Aortic body and other paraganglia	0.001	0.999	0.000
D35.5 Carotid body	0.001	0.999	0.000
D35.4 Pineal gland	0.001	0.999	0.000
D35.3 Craniopharyngeal duct	0.001	0.999	0.000
K91.9 Postprocedural disorder of digestive system, unspecified	0.001	0.999	0.000
K91.8 Other postprocedural disorders of digestive system, not elsewhere classified	0.001	0.999	0.000
K91.5 Postcholecystectomy syndrome	0.001	0.999	0.000
K91.2 Postsurgical malabsorption, not elsewhere classified	0.001	0.999	0.000
K91.1 Postgastric surgery syndromes	0.001	0.999	0.000
O75.6 Delayed delivery after spontaneous or unspecified rupture of membranes	0.001	0.999	0.000
Y43.4 Immunosuppressive agents	0.001	0.999	0.000
Y54.5 Other diuretics	0.001	0.999	0.000
Y57.5 X-ray contrast media	0.001	0.999	0.000
C45 Mesothelioma	0.001	0.999	0.000
C97 Malignant neoplasms of independent (primary) multiple sites	0.001	0.999	0.000
D35.0 Adrenal gland	0.001	0.999	0.000
D75.1 Secondary polycythaemia	0.001	0.999	0.000
H42.8 Glaucoma in other diseases classified elsewhere	0.000	0.999	0.001
H42.0 Glaucoma in endocrine, nutritional and metabolic diseases	0.000	0.999	0.001
Y49.9 Psychotropic drug, unspecified	0.001	0.999	0.000
Y49.8 Other psychotropic drugs, not elsewhere classified	0.001	0.999	0.000
Y49.7 Psychostimulants with abuse potential	0.001	0.999	0.000
Y49.6 Psychodysleptics [hallucinogens]	0.001	0.999	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations